Aurinia Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need.
2025/9/5 10:37:45
(AUPH:NASDAQ - AUP:TSX)